501 related articles for article (PubMed ID: 19673644)
21. Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA.
Poovelikunnel T; Gethin G; Humphreys H
J Antimicrob Chemother; 2015 Oct; 70(10):2681-92. PubMed ID: 26142407
[TBL] [Abstract][Full Text] [Related]
22. [Mupirocin resistance in methicillin-resistant Staphylococcus aureus strains isolated from wound infections].
Dolapçi I; Karahan ZC; Tekeli A; Koyuncu E; Azap A; Adaleti R
Mikrobiyol Bul; 2007 Jul; 41(3):435-40. PubMed ID: 17933255
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of resistance to mupirocin in methicillin-resistant Staphylococcus aureus isolates in a tertiary hospital in Spain.
Daskalaki M; Otero JR; Chaves F
J Antimicrob Chemother; 2009 Apr; 63(4):826-8. PubMed ID: 19223301
[No Abstract] [Full Text] [Related]
24. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study.
Lee AS; Macedo-Vinas M; François P; Renzi G; Schrenzel J; Vernaz N; Pittet D; Harbarth S
Clin Infect Dis; 2011 Jun; 52(12):1422-30. PubMed ID: 21628482
[TBL] [Abstract][Full Text] [Related]
25. Acquisition of high-level mupirocin resistance and its fitness cost among methicillin-resistant Staphylococcus aureus strains with low-level mupirocin resistance.
Mongkolrattanothai K; Pumfrey L; Mankin P; Gray BM
J Clin Microbiol; 2009 Dec; 47(12):4158-60. PubMed ID: 19812270
[TBL] [Abstract][Full Text] [Related]
26. Mupirocin resistance is not an inevitable consequence of mupirocin use.
Talon D; Marion C; Thouverez M; Bertrand X
J Hosp Infect; 2011 Dec; 79(4):366-7. PubMed ID: 21968283
[TBL] [Abstract][Full Text] [Related]
27. [Development of mupirocin resistance during eradication treatment of methicillin resistant Staphylococcus aureus carriage].
Kirk KF
Ugeskr Laeger; 2012 May; 174(19):1310-1. PubMed ID: 22564689
[TBL] [Abstract][Full Text] [Related]
28. Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005.
Wiese-Posselt M; Heuck D; Draeger A; Mielke M; Witte W; Ammon A; Hamouda O
Clin Infect Dis; 2007 Jun; 44(11):e88-95. PubMed ID: 17479931
[TBL] [Abstract][Full Text] [Related]
29. Diversity of plasmids and transmission of high-level mupirocin mupA resistance gene in Staphylococcus haemolyticus.
do Carmo Ferreira N; Schuenck RP; dos Santos KR; de Freire Bastos Mdo C; Giambiagi-deMarval M
FEMS Immunol Med Microbiol; 2011 Mar; 61(2):147-52. PubMed ID: 21182545
[TBL] [Abstract][Full Text] [Related]
30. Rapid and simultaneous detection of the chlorhexidine and mupirocin resistance genes qacA/B and mupA in clinical isolates of methicillin-resistant Staphylococcus aureus.
Mc Gann P; Milillo M; Kwak YI; Quintero R; Waterman PE; Lesho E
Diagn Microbiol Infect Dis; 2013 Nov; 77(3):270-2. PubMed ID: 24034900
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus.
LaPlante KL
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):413-8. PubMed ID: 17141452
[TBL] [Abstract][Full Text] [Related]
32. Low prevalence of mupirocin resistance among Staphylococcus aureus clinical isolates from a Chinese tertiary hospital.
Chen S; Jin Y; Lin C; Hao Z; Duan J; Guo Y; Wang S; Hu L; Wang L; Yu F
J Med Microbiol; 2019 Feb; 68(2):201-205. PubMed ID: 30570481
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of disc diffusion methods and Vitek 2 automated system for testing susceptibility to mupirocin in Staphylococcus aureus.
Malaviolle X; Nonhoff C; Denis O; Rottiers S; Struelens MJ
J Antimicrob Chemother; 2008 Nov; 62(5):1018-23. PubMed ID: 18765413
[TBL] [Abstract][Full Text] [Related]
34. Decrease in the incidence of mupirocin resistance among methicillin-resistant Staphylococcus aureus in carriers from an intensive care unit.
Caierão J; Berquó L; Dias C; d'Azevedo PA
Am J Infect Control; 2006 Feb; 34(1):6-9. PubMed ID: 16443086
[TBL] [Abstract][Full Text] [Related]
35. The prevalence of methicillin resistant Staphylococcus aureus (MRSA) isolates with high-level mupirocin resistance from patients and personnel in a burn center.
Abbasi-Montazeri E; Khosravi AD; Feizabadi MM; Goodarzi H; Khoramrooz SS; Mirzaii M; Kalantar E; Darban-Sarokhalil D
Burns; 2013 Jun; 39(4):650-4. PubMed ID: 23499497
[TBL] [Abstract][Full Text] [Related]
36. Chronicity of high and low level mupirocin resistance in Staphylococcus aureus from 30 Indian hospitals.
Prakash R; Garg A; Arya R; Kumawat RK
Sci Rep; 2023 Jun; 13(1):10171. PubMed ID: 37349503
[TBL] [Abstract][Full Text] [Related]
37. Mupirocin resistance among Iranian isolates of Staphylococcus aureus.
Saderi H; Owlia P; Habibi M
Med Sci Monit; 2008 Oct; 14(10):BR210-3. PubMed ID: 18830185
[TBL] [Abstract][Full Text] [Related]
38. Acquisition of high-level mupirocin resistance in CoNS following nasal decolonization with mupirocin.
Hetem DJ; Vogely HC; Severs TT; Troelstra A; Kusters JG; Bonten MJ
J Antimicrob Chemother; 2015 Apr; 70(4):1182-4. PubMed ID: 25538164
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of prevalence of low and high level mupirocin resistance in methicillin resistant Staphylococcus aureus isolates at a tertiary care hospital.
Nizamuddin S; Irfan S; Zafar A
J Pak Med Assoc; 2011 Jun; 61(6):519-21. PubMed ID: 22204200
[TBL] [Abstract][Full Text] [Related]
40. Clonal variation in high- and low-level phenotypic and genotypic mupirocin resistance of MRSA isolates in south-east London.
Hughes J; Stabler R; Gaunt M; Karadag T; Desai N; Betley J; Ioannou A; Aryee A; Hearn P; Marbach H; Patel A; Otter JA; Edgeworth JD; Tosas Auguet O
J Antimicrob Chemother; 2015 Dec; 70(12):3191-9. PubMed ID: 26316381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
